S1. Experimental Details
Materials: ZrCl 4 (99.5%) and terephthalic acid (98%) from Alfa Aesar (UK). Benzoic acid (99.5%), HCl (37%), acetic acid (≥99%), dimethylformamide (DMF, 99.8%), methanol (99.9%), acetone (99.9%), nystatin, sucrose (99.5%), rottlerin and calcein disodium salt from Sigma-Aldrich (UK). Dulbecco's modified Eagle's medium (DMEM), foetal bovine serum (FBS), L-glutamine, penicillin, and streptomycin from Invitrogen (UK). Phosphate-buffered saline (PBS), trypsin-EDTA, and Lysotracker ® -Deep Red from Life Technologies™ (UK). The CellTiter 96 ® AQueous One Solution Cell Proliferation Assay (MTS) was obtained from Promega (UK). All chemicals and biochemicals used were of analytical grade. HeLa cells were obtained from the ATCC. Instruments: PXRD and TGA data as well as SEM images for Zr-Lx were obtained as described in our previous work. 2 Field-Emission Scanning Electron Microscopy (FESEM) images of the xZr-L1 crystals were collected on a FEI Magellan 400L scanning electron microscope at acceleration voltage of 2.0 kV, using aluminium as support. Mean particle size distribution of the x Zr-L1 crystals was carried out by statistical analysis of the SEM images (based on at least 120 particle measurements per sample). Colloidal analysis in phosphate-buffered saline (PBS) and growth media at room temperature was determined by dynamic light scattering (DLS) with a Brookhaven Zeta Plus potential analyzer (detection angle of 90º and a 35 mW laser). Synthesis: In a typical x Zr-L1 synthesis, 5 mL of a DMF solution of terephthalic acid (BDC; 20 mg, 8.0 mM) was added to 10 mL of a DMF solution containing varying amounts of acetic acid (HAc) and ZrCl 4 (28 mg, 8.0 mM) in a 26 mL glass vial with strong magnetic stirring. Once the addition was completed, the stirring was stopped and the vials were sealed and introduced into an oven at 120 °C for 24 hours. The resulting powders were collected by centrifugation (6701 rcf in 50-mL Falcon tubes), re-dispersed in 10 mL of DMF and precipitated by centrifugation. This two-step washing process was repeated two more times with DMF to remove the unreacted BDC. UiO-66 particles were further washed three times with methanol and left under stirring at 50 ºC for 24 hours to remove the DMF. The collected UiO-66 particles were finally dried at room temperature under vacuum overnight. The concentrations of acetic acid used to synthesize the UiO-66 particles of each size were: for 50 ± 2 nm, Zr-L2-Zr-L6 were synthesized according to our previously reported methodology.
1
Cargo loading experiments: Calcein was loaded into the MOFs as described in our previous work. 2 α-CHC loading was described elsewhere. 1 The amount of calcein adsorbed was quantified by measuring the remaining calcein in the supernatant using UV-vis. The amount of α-CHC adsorbed was determined by measuring the remaining amount of drug present in the supernatant after the first centrifugation step. Cell culture: HeLa cells were cultured at 37 ºC with 5% CO 2 in high rich glucose (4500 mg/L) DMEM with phenol red supplemented with 10% (v/v) FBS, 2 mM L-glutamine, 100 units/mL penicillin and 100 µg/mL streptomycin. This was named complete DMEM (cDMEM). The cells were passaged three times a week. Cytotoxicity assays: The cytotoxicity activities of the inhibitors, MOFs, and drug-loaded MOFs, were investigated using the MTS (Promega, UK) reduction assay. The procedure for the assay as well as the results for the inhibitors' cytotoxicity were reported in our previous work. 2 
Flow cytometry assays:
In all the flow cytometry experiments, after any treatment, cells were collected and analysed as described in our previous work. 2 Energy dependence assay was performed by pretreating cells at either 4 or 37 ºC followed by measuring fluorescence with flow cytometry as described before. The procedure for treating cells with inhibitors was also described in the same work.
2 Positive controls for the inhibition studies using endocytosis tracers (transferrin-AlexaFluor-633, 25 µg/mL; BODIPY TR-ceramide, 3.5 µg/mL; and Texas Red-dextran-10kDa, 0.5 mg/mL) were reported in our previous work. 2 Efficiency of UiO-66 uptake: HeLa cells were seeded in a Cellstar 24-well plate at a density of 5 x 10 4 cell/well and incubated for 48 h at 37 ºC with 5% CO 2 in cDMEM. Then, each well was washed with PBS and cells were incubated with the required concentration of MOF for 2 h (this time was previously optimized for UiO-66 in order to avoid activating compensatory uptake mechanisms) 2 . Subsequently, samples were measured by flow cytometry.
Co-localization experiments:
For all the co-localization experiments with LysoTracker ® -Deep red, HeLa cells were treated and imaged as described in our previous work. 200-300 300-400 400-500 500-600 600-700 700-800 800-900 900-1000 >1000
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